Saito, Takao

A flexible and wearable biosensor for tear glucose measurement

Iguchi, S., Kudo, H., Saito, T., Ogawa, M., Saito, H., Otsuka, K., Funakubo, A., & Mitsubayashi, K. (2007) · Biomedical Microdevices

Electrochemical sensors and biosensorsAnalytical Chemistry and Sensors

Cited by 173

Lipoprotein Glomerulopathy: Glomerular Lipoprotein Thrombi in a Patient With Hyperlipoproteinemia

Saito, T., Sato, H., Kudo, K.-I., Oikawa, S.-I., Shibata, T., Hara, Y., Yoshinaga, K., & Sakaguchi, H. (1989) · American Journal of Kidney Diseases

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 148

Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.

Oikawa, S., Matsunaga, A., Saito, T., Sato, H., Seki, T., Hoshi, K., Hayasaka, K., Kotake, H., Midorikawa, H., Sekikawa, A., et al. (1997) · Journal of the American Society of Nephrology

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 103

Impact of Lipoprotein Glomerulopathy on the Relationship Between Lipids and Renal Diseases

Saito, T., Matsunaga, A., & Oikawa, S. (2006) · American Journal of Kidney Diseases

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 96

Contribution of mononuclear leucocytes to the progression of experimental focal glomerular sclerosis

Saito, T., & Atkins, R. C. (1990) · Kidney International

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 96

Apolipoprotein E–related glomerular disorders

Saito, T., Matsunaga, A., Fukunaga, M., Nagahama, K., Hara, S., & Muso, E. (2020) · Kidney International

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 77

Virus-mediated Transduction of Apolipoprotein E (ApoE)-Sendai Develops Lipoprotein Glomerulopathy in ApoE-deficient Mice

Ishigaki, Y., Oikawa, S., Suzuki, T., Usui, S., Magoori, K., Kim, D.-H., Suzuki, H., Sasaki, J., Sasano, H., Okazaki, M., et al. (2000) · Journal of Biological Chemistry

Lipid metabolism and disordersRenal Diseases and Glomerulopathies

Cited by 58

Lipoprotein Glomerulopathy

Saito, T., Sato, H., Oikawa, S., Kudo, K., Kurihara, I., Nakayama, K., Abe, K., Yoshinaga, K., & Sakaguchi, H. (1993) · American Journal of Nephrology

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 57

Association of a Novel 3-Amino Acid Deletion Mutation of Apolipoprotein E (Apo E Tokyo) with Lipoprotein Glomerulopathy

Konishi, K., Saruta, T., Kuramochi, S., Oikawa, S., Saito, T., Han, H., Matsunaga, A., & Sasaki, J. (1999) · Nephron

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 54

A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy

Ando, M., Sasaki, J., Hua, H., Matsunaga, A., Uchida, K., Jou, K., Oikawa, S., Saito, T., & Nihei, H. (1999) · Kidney International

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 53

Lipoprotein glomerulopathy: renal lipidosis induced by novel apolipoprotein E variants

Saito, T., Oikawa, S., Sato, H., & Sasaki, J. (1999) · Nephron

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 46

Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features

Saito, T., Oikawa, S., Sato, H., Sato, T., Ito, S., & Sasaki, J. (1999) · Kidney International

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 37

Abnormal lipid metabolism and renal disorders

Saito, T. (1997) · The Tohoku Journal of Experimental Medicine

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 35

Topics in lipoprotein glomerulopathy: an overview

Saito, T., Matsunaga, A., Ito, K., & Nakashima, H. (2014) · Clinical and Experimental Nephrology

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 33

Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia

Matsunaga, A., & Saito, T. (2014) · Clinical and Experimental Nephrology

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 33

A Novel Mutation ApoE2 Kurashiki (R158P) in a Patient with Lipoprotein Glomerulopathy

Tokura, T., Itano, S., Kobayashi, S., Kuwabara, A., Fujimoto, S., Horike, H., Satoh, M., Komai, N., Tomita, N., Matsunaga, A., et al. (2011) · Journal of Atherosclerosis and Thrombosis

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 28

Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy

Saito, T., Ishigaki, Y., Oikawa, S., & Yamamoto, T. T. (2002) · Trends in Cardiovascular Medicine

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 25

Macrophage impairment produced by Fc receptor gamma deficiency plays a principal role in the development of lipoprotein glomerulopathy in concert with apoE abnormalities

Ito, K., Nakashima, H., Watanabe, M., Ishimura, A., Miyahara, Y., Abe, Y., Yasuno, T., Ifuku, M., Sasatomi, Y., & Saito, T. (2012) · Nephrology Dialysis Transplantation

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 21

A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy

Toyota, K., Hashimoto, T., Ogino, D., Matsunaga, A., Ito, M., Masakane, I., Degawa, N., Sato, H., Shirai, S., Umetsu, K., et al. (2013) · Journal of Human Genetics

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 19

Lipoprotein glomerulopathy may provide a key to unlock the puzzles of renal lipidosis

Saito, T., & Matsunaga, A. (2014) · Kidney International

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 18

Role of apolipoprotein E variants in lipoprotein glomerulopathy and other renal lipidoses

Saito, T., Ishigaki, Y., Oikawa, S., & Yamamoto, T. T. (2001) · Clinical and Experimental Nephrology

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 18

A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate

Kodera, H., Mizutani, Y., Sugiyama, S., Miyata, T., Ehara, T., Matsunaga, A., & Saito, T. (2017) · Case Reports in Nephrology and Dialysis

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 17

Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice

Ishimura, A., Watanabe, M., Nakashima, H., Ito, K., Miyake, K., Mochizuki, S., Ishigaki, Y., & Saito, T. (2009) · Clinical and Experimental Nephrology

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 17

Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features

Matsunaga, A., & Saito, T. (2025) · Journal of Atherosclerosis and Thrombosis

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 14